close

Enter

Log in using OpenID

China Bioprocess Instruments Market Size

embedDownload
China bioprocess instruments market size was estimated at USD 1.18 billion in 2016 and is expected to grow on account of the evolution of new technologies.
Your Catalyst To a Lucrative Business
China Bioprocess Instruments Market Size, Share, Growth,
Analysis and Forecast to 2024 - Hexa Research
“China bioprocess instruments market is expected to
reach USD 3.06 billion by 2024 owing to the improving
economy, rising aging population and increasing
prevalence of chronic diseases.”
The China Bioprocess Instruments Market is expected to reach USD 3.06 billion by 2024 owing to the
improving economy, rising aging population and increasing prevalence of chronic diseases. Moreover,
increasing demand for single-use instruments in disposable applications is anticipated to augment the growth
over the projected period.
China was the second largest pharmaceutical market in the world, expected to grow USD 173 billion by 2024,
growing at a CAGR of 9.1% owing to the requirement of medication & drugs to cure deadly diseases. Huge
investment in biotechnology will primarily drive the growth of the market, as pharma companies deal in
innovations for developing medicines and drugs in line with the increasing prevalence of diseases.
Browse Details of Report @ https://www.hexaresearch.com/research-report/china-bioprocessinstruments-market
Follow Us:
Your Catalyst To a Lucrative Business
With the patents of numerous biopharmaceutical products expiring by 2016, the market is anticipated to
provide a lucrative opportunity for contract manufacturers operating in the region. Approval of the trail plan
for new drug marketing authorization holder (MAH) in 2016 to produce, conduct clinical trials, and market
the products is expected to provide an impetus to the growth of the industry over the next few years.
Increasing demand for bioprocess instruments in the pharmaceutical, research & development, industrial and
medical laboratories coupled with the increasing number of these facilities is expected to result in the growth
of the market. Change in lifestyle & food consuming habits, and growing levels of air & water pollution have
led to increasing occurrence of disease including obesity which has resulted in a rising number of patients
diagnosed with cancer, heart disease, diabetes and other chronic conditions. Thus, the healthcare sector is
anticipated to create demand for treatment and laboratory services, which will result in the growth of
bioprocess instruments market over the forecast period.
Stringent regulatory policies and the high cost of instruments are likely to restrain the bioprocess instruments
market in China. The government has been focusing on reducing the fragmentation in the industry by
consolidating manufacturers that lack standards in production with larger companies. This move will help in
preventing the quality risks and sub-par manufacturers entering the market. Shortage of skilled labor is
another challenge in the growth of bioprocessing industry.
Koninklijke Philips N.V., Thermo Fisher Scientific Inc. and Becton, Dickinson and Company were the top three
companies in the market in China in 2016. Companies are extensively investing in R&D for innov ation and
new product development. In addition, companies are adopting the strategy of merger and acquisition to
expand their product portfolio.
Hexa Research has segmented the China bioprocess instruments market based on type:
Segmentation by type, 2014 - 2024 (USD Million)
• Cell Expansion
• Flow Cytometry
• Biologics Safety Testing
• Cell Line Development
• Tangential Flow Filtration
• Cell Counters
• Virus Filtration
• Cell Culture
• Pyrogen Testing
Follow Us:
Your Catalyst To a Lucrative Business
• Single-Use Bioprocessing
Browse Related Category Market Reports @ https://www.hexaresearch.com/researchcategory/pharmaceuticals-industry
Follow Us:
Your Catalyst To a Lucrative Business
Table of Content of China Bioprocess Instruments Market
Chapter 1 Market Summary
1.1 Market trends & movement
Chapter 2 Bioprocess Instruments Market Trends: Drivers & Opportunities
2.1 Introduction
2.2 Key industry trends
2.3 Market driver analysis
2.3.1 Rising prevalence of chronic diseases
2.3.2 Growth in R&D activities in biopharmaceutical industry and life sciences
2.3.3 Market restraint
2.3.4 Stringent regulatory policies
2.4 Value chain analysis
2.5 SWOT
2.6 Porter’s Five Forces’ analysis
Chapter 3 Bioprocess Instruments Market, By Type
3.1 Bioprocess instruments market movement, by type, 2016 & 2024
3.2 Cell Expansion
3.2.1 Market estimates and forecast, 2014 - 2024 (USD Million)
3.3 Flow Cytometry
3.3.1 Market estimates and forecast, 2014 - 2024 (USD Million)
3.4 Biological Safety Testing
3.4.1 Market estimates and forecast, 2014 - 2024 (USD Million)
3.5 Cell Line Development
3.5.1 Market estimates and forecast, 2014 - 2024 (USD Million)
3.6 Tangential Flow Filtration
3.6.1 Market estimates and forecast, 2014 - 2024 (USD Million)
3.7 Cell Counter
3.7.1 Market estimates and forecast, 2014 - 2024 (USD Million)
3.8 Cell Culture
3.8.1 Market estimates and forecast, 2014 - 2024 (USD Million)
3.9 Pyrogen Testing
3.9.1 Market estimates and forecast, 2014 - 2024 (USD Million)
3.10 Single Use Bioprocessing
3.10.1 Market estimates and forecast, 2014 - 2024 (USD Million)
3.11 Virus Filtration
Follow Us:
Your Catalyst To a Lucrative Business
3.11.1 Market estimates and forecast, 2014 - 2024 (USD Million)
Chapter 4 Competitive Landscape
4.1 Competitive landscape analysis, 2016
4.2 Strategic framework
4.3 Potential customer base
4.4 Company market positioning
4.5 Company profiles
4.5.1 Abbott
4.5.1.1 Company Overview
4.5.1.2 Financial performance
4.5.1.3 Product benchmarking
4.5.1.4 Recent Initiatives
4.5.2 Thermo Fisher Scientific Inc.
4.5.2.1 Company Overview
4.5.2.2 Product benchmarking
4.5.2.3 Financial performance
4.5.2.4 Recent Initiatives
4.5.3 Alere Inc.
4.5.3.1 Company overview
4.5.3.2 Product benchmarking
4.5.3.3 Financial performance
4.5.3.4 Recent Initiatives
4.5.4 Becton, Dickinson and Company (BD)
4.5.4.1 Company Overview
4.5.4.2 Product benchmarking
4.5.4.3 Financial performance
4.5.4.4 Recent Initiatives
4.5.5 Koninklijke Philips N.V.
4.5.5.1 Company Overview
4.5.5.2 Product benchmarking
4.5.5.3 Financial performance
4.5.5.4 Recent Initiatives
4.5.6 PerkinElmer, Inc.
4.5.6.1 Company overview
4.5.6.2 Financial performance
4.5.6.3 Product benchmarking
Follow Us:
Your Catalyst To a Lucrative Business
4.5.6.4 Recent Initiatives
4.5.7 Danaher
4.5.7.1 Company Overview
4.5.7.2 Financial performance
4.5.7.3 Recent Initiatives
4.5.8 SHIMADZU CORPORATION
4.5.8.1 Company overview
4.5.8.2 Financial performance
4.5.8.3 Product benchmarking
4.5.8.4 Recent Initiatives
4.5.9 CESCO BIOENGINEERING CO., LTD
4.5.9.1 Company overview
4.5.9.2 Product benchmarking
4.5.10 Shanghai RITAI medicine equipment project co., ltd
4.5.10.1 Company overview
4.5.10.2 Product benchmarking
4.6 List of Other Vendors
Chapter 5 Methodology and Scope
5.1 Research Methodology
5.2 Research Scope & Assumptions
5.3 List of Data Sources
Follow Us:
Your Catalyst To a Lucrative Business
About Us:
Hexa Research is a market research and consulting organization, offering industry reports, custom research
and consulting services to a host of key industries across the globe. We offer comprehensive business
intelligence in the form of industry reports which help our clients obtain clarity about their business
environment and enable them to undertake strategic growth initiatives.
Contact Us:
Ryan Shaw
Hexa Research
Felton Office Plaza
6265 Highway 9
Felton, California 95018
United States
Phone: +1-800-489-3075
Email: [email protected]
Website - http://www.hexaresearch.com/
Follow Us:
Author
sara01.james
sara01.james490   documents Email
Document
Category
Health and Medicine
Views
27
File Size
746 KB
Tags
bioprocess, healthcare, instruments, market, china, Pharmaceuticals
1/--pages
Report inappropriate content